Advanced Asset Management Advisors’s Invesco Pharmaceuticals ETF PJP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
– Sell
-25
Closed -$2K – 99
2020
Q4
$2K Buy
+25
New +$1.67K ﹤0.01% 97
2020
Q2
– Sell
-74
Closed -$4K – 115
2020
Q1
$4K Sell
74
-24
-24% -$1.46K ﹤0.01% 115
2019
Q4
$6K Buy
+98
New +$5.96K ﹤0.01% 119

Other funds holding PJP

Advanced Asset Management Advisors's PJP Position: Q1 2021 in Review

Advanced Asset Management Advisors sold out of Invesco Pharmaceuticals ETF (PJP) in Q1 2021, closing a stake of 25 shares — an estimated $2K sold.

Advanced Asset Management Advisors first reported a position in PJP in Q4 2019 and held it in 3 quarters. The position peaked at $6K in Q4 2019. 89 funds tracked by Wall St. Rank hold PJP as of Q1 2021.

  • Advanced Asset Management Advisors reported no remaining Invesco Pharmaceuticals ETF position as of Q1 2021 after selling out during the quarter.
  • Advanced Asset Management Advisors sold 25 Invesco Pharmaceuticals ETF shares in Q1 2021, an estimated $2K.
  • Advanced Asset Management Advisors first reported a position in Invesco Pharmaceuticals ETF in Q4 2019 and held it in 3 quarters.
  • Advanced Asset Management Advisors's Invesco Pharmaceuticals ETF position peaked at $6K in Q4 2019.
  • 89 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q1 2021.

Based on Advanced Asset Management Advisors's 13F filing for Q1 2021, filed 3 May 2021.